MARC HOROWITZ

Concepts (284)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Combined Chemotherapy Protocols
30
2006
1232
0.680
Why?
Brain Neoplasms
24
2013
1236
0.660
Why?
Sarcoma
11
1998
194
0.470
Why?
Survivors
3
2022
345
0.460
Why?
Bone Neoplasms
11
1996
431
0.460
Why?
Sarcoma, Ewing
10
1996
117
0.450
Why?
Soft Tissue Neoplasms
8
1996
130
0.400
Why?
Ependymoma
8
2013
134
0.310
Why?
Cyclophosphamide
6
2005
422
0.290
Why?
Neoplasms
8
2022
2755
0.280
Why?
Rhabdomyosarcoma
10
1996
200
0.260
Why?
Antineoplastic Agents
7
2013
1660
0.250
Why?
Neoplasms, Germ Cell and Embryonal
3
2005
88
0.240
Why?
Work Schedule Tolerance
1
2003
38
0.220
Why?
Child, Preschool
38
2014
13888
0.200
Why?
Burnout, Professional
1
2003
114
0.190
Why?
Combined Modality Therapy
21
1999
1236
0.190
Why?
Doxorubicin
5
1996
300
0.180
Why?
Decision Support Systems, Clinical
1
2022
170
0.170
Why?
Internet
2
2022
378
0.160
Why?
Stress, Psychological
1
2003
556
0.160
Why?
Thiotepa
2
1995
15
0.150
Why?
Kidney Tubules
6
1987
82
0.150
Why?
Thrombocytopenia
2
1996
228
0.140
Why?
Child
37
2022
24228
0.130
Why?
Agranulocytosis
1
1996
14
0.130
Why?
Razoxane
1
1996
10
0.130
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1996
66
0.130
Why?
Cisplatin
5
1995
242
0.120
Why?
Antibiotics, Antineoplastic
1
1996
126
0.120
Why?
Cardiovascular Agents
1
1996
86
0.120
Why?
Infant
25
2013
12357
0.120
Why?
Cancer Survivors
1
2018
199
0.120
Why?
Medulloblastoma
5
2013
338
0.110
Why?
Ifosfamide
6
1996
39
0.110
Why?
Whole-Body Irradiation
1
1993
65
0.110
Why?
Humans
63
2022
123103
0.110
Why?
Education, Medical, Graduate
2
2010
507
0.100
Why?
Neuroectodermal Tumors, Primitive, Peripheral
4
1996
18
0.100
Why?
Adolescent
29
2006
19094
0.100
Why?
Glioma
8
2006
496
0.100
Why?
Bone Marrow Transplantation
2
1999
578
0.100
Why?
Lung Neoplasms
4
1998
1593
0.100
Why?
Male
36
2013
60129
0.090
Why?
Heart
1
1996
723
0.090
Why?
Neoplasms, Second Primary
3
1998
152
0.090
Why?
Adult
26
2006
29009
0.090
Why?
Female
35
2013
65514
0.080
Why?
Schools, Medical
1
2010
114
0.080
Why?
Survival Analysis
8
2006
1473
0.080
Why?
Disease-Free Survival
4
2006
859
0.070
Why?
Leadership
1
2010
230
0.070
Why?
Pilot Projects
4
1999
1389
0.070
Why?
Osteosarcoma
6
1995
258
0.070
Why?
Rhabdoid Tumor
2
1997
49
0.070
Why?
Glioblastoma
3
1996
334
0.070
Why?
Etoposide
3
1996
117
0.070
Why?
Vincristine
3
1996
196
0.060
Why?
Drug Administration Schedule
6
1998
720
0.060
Why?
Injections, Spinal
1
2005
118
0.060
Why?
Maximum Tolerated Dose
1
2005
157
0.060
Why?
Morphine
1
2005
88
0.060
Why?
Chromosome Aberrations
3
1995
614
0.060
Why?
Headache
1
2005
108
0.060
Why?
Switzerland
1
2003
16
0.060
Why?
Affect
1
2005
157
0.060
Why?
Misonidazole
1
1983
2
0.060
Why?
Radiotherapy, Adjuvant
3
1999
142
0.050
Why?
Survival Rate
7
1999
1999
0.050
Why?
Dexamethasone
1
2005
271
0.050
Why?
Nitroimidazoles
1
1983
45
0.050
Why?
Workload
1
2003
146
0.050
Why?
Survivorship
1
2022
36
0.050
Why?
Glucocorticoids
1
2005
377
0.050
Why?
Pain
1
2005
469
0.050
Why?
Carrier Proteins
4
2006
1017
0.050
Why?
Analgesics, Opioid
1
2005
402
0.040
Why?
Follow-Up Studies
8
1998
5039
0.040
Why?
Mesna
3
1989
10
0.040
Why?
Pinealoma
2
1999
19
0.040
Why?
Radiotherapy Dosage
4
1996
185
0.040
Why?
Cranial Irradiation
2
1999
69
0.040
Why?
Neurilemmoma
4
1993
46
0.040
Why?
Mercaptoethanol
2
1989
6
0.040
Why?
Kidney Diseases
3
1987
478
0.040
Why?
Age Factors
1
2005
2799
0.040
Why?
Prognosis
8
1998
4512
0.040
Why?
Liver Neoplasms
2
1987
1311
0.040
Why?
Patient Care Planning
1
2018
121
0.030
Why?
Prospective Studies
5
1996
6028
0.030
Why?
Acetylglucosaminidase
5
1987
17
0.030
Why?
Neoplasms, Radiation-Induced
1
1996
81
0.030
Why?
Camptothecin
1
1996
76
0.030
Why?
Postoperative Period
3
1998
330
0.030
Why?
Transaminases
1
1996
32
0.030
Why?
Neoplasms, Experimental
4
1983
212
0.030
Why?
Injections, Intravenous
1
1996
252
0.030
Why?
Astrocytoma
3
1993
103
0.030
Why?
Pineal Gland
1
1995
17
0.030
Why?
Hematopoiesis, Extramedullary
1
1995
9
0.030
Why?
Choroid Plexus Neoplasms
1
1995
14
0.030
Why?
Guideline Adherence
1
2018
375
0.030
Why?
Karyotyping
3
1995
330
0.030
Why?
Thymus Gland
1
1995
100
0.030
Why?
Neutropenia
1
1996
202
0.030
Why?
Aminopeptidases
4
1987
19
0.030
Why?
CD13 Antigens
4
1987
15
0.030
Why?
Drug Evaluation
6
1992
111
0.030
Why?
Lymphocyte Depletion
1
1994
124
0.030
Why?
L-Lactate Dehydrogenase
2
1991
61
0.030
Why?
Ganglioglioma
1
1994
24
0.030
Why?
Foot
1
1994
63
0.030
Why?
Tomography, X-Ray Computed
3
1993
2055
0.030
Why?
Pneumonectomy
1
1995
129
0.030
Why?
Proteinuria
4
1987
110
0.030
Why?
Stroke Volume
1
1996
445
0.030
Why?
Nevus, Pigmented
1
1993
32
0.030
Why?
Nitrosourea Compounds
2
1983
4
0.030
Why?
Ethylnitrosourea
2
1983
11
0.030
Why?
Retroperitoneal Neoplasms
1
1993
31
0.030
Why?
Hand
1
1994
101
0.030
Why?
Supratentorial Neoplasms
1
2013
37
0.030
Why?
Internship and Residency
1
2003
1158
0.030
Why?
Treatment Outcome
5
2013
12115
0.030
Why?
Neoplasm Proteins
2
1994
668
0.030
Why?
Cholecystokinin
1
1992
14
0.030
Why?
Blood-Brain Barrier
2
1983
141
0.030
Why?
Carcinoma
1
1995
278
0.030
Why?
Pentetic Acid
1
1992
10
0.020
Why?
Topotecan
2
2006
49
0.020
Why?
Meglumine
1
1992
15
0.020
Why?
Gadolinium DTPA
1
1992
48
0.020
Why?
Membrane Glycoproteins
1
1994
411
0.020
Why?
CD4-Positive T-Lymphocytes
1
1995
472
0.020
Why?
Cerebrovascular Circulation
3
1983
434
0.020
Why?
Organometallic Compounds
1
1992
106
0.020
Why?
Osteotomy
1
1991
39
0.020
Why?
Extremities
1
1991
83
0.020
Why?
Hot Temperature
1
1971
135
0.020
Why?
Thoracotomy
1
1992
108
0.020
Why?
Drug Combinations
1
1992
269
0.020
Why?
Practice Guidelines as Topic
1
2018
1258
0.020
Why?
Neoplasm Recurrence, Local
2
1993
1118
0.020
Why?
Central Nervous System Neoplasms
1
1992
194
0.020
Why?
Professional Competence
1
2010
97
0.020
Why?
Methotrexate
2
1990
341
0.020
Why?
Heart Rate
1
1971
587
0.020
Why?
Contrast Media
1
1992
470
0.020
Why?
Aging
1
1995
1176
0.020
Why?
Hospitalization
1
1996
1739
0.020
Why?
Fibroma
1
1987
30
0.020
Why?
Creatinine
2
1987
380
0.020
Why?
Clinical Trials as Topic
2
1996
1080
0.020
Why?
Thymectomy
1
1987
19
0.020
Why?
Organoplatinum Compounds
1
1987
29
0.020
Why?
Infant, Newborn
3
1999
8106
0.020
Why?
Autoradiography
2
1983
71
0.020
Why?
Sensitivity and Specificity
1
1992
2011
0.020
Why?
Blood
1
1987
105
0.020
Why?
Neuroectodermal Tumors, Primitive
2
1999
52
0.020
Why?
Rats, Inbred F344
2
1983
105
0.020
Why?
Neoplasm Metastasis
2
1986
653
0.020
Why?
Skin Neoplasms
1
1993
796
0.020
Why?
Mice, Inbred Strains
1
1987
311
0.020
Why?
Procarbazine
1
2006
13
0.020
Why?
Microscopy, Electron
1
1987
391
0.020
Why?
Magnetic Resonance Imaging
3
1993
3545
0.020
Why?
MutS Homolog 2 Protein
1
2006
37
0.020
Why?
Nervous System
1
1987
128
0.020
Why?
Alkyl and Aryl Transferases
1
2006
18
0.020
Why?
MutL Protein Homolog 1
1
2006
54
0.020
Why?
Neoplasm Transplantation
1
1987
369
0.020
Why?
Regional Blood Flow
2
1983
213
0.020
Why?
DNA, Neoplasm
1
1987
300
0.020
Why?
Tissue Distribution
2
1983
382
0.020
Why?
Chemotherapy, Adjuvant
2
1999
353
0.020
Why?
Chromosomes, Human, 1-3
1
1985
2
0.020
Why?
Dose-Response Relationship, Drug
3
1995
1681
0.020
Why?
Child Development
1
1988
261
0.020
Why?
Neoplasm, Residual
1
2006
121
0.020
Why?
Preoperative Care
1
1987
348
0.020
Why?
Cell Division
1
1987
780
0.020
Why?
Rats
4
1983
3651
0.010
Why?
Gene Expression Regulation, Neoplastic
1
1992
1872
0.010
Why?
Flow Cytometry
1
1987
803
0.010
Why?
Anti-Bacterial Agents
1
1996
2393
0.010
Why?
Lung
1
1992
1463
0.010
Why?
Neoplasm Staging
3
1994
1213
0.010
Why?
Treatment Failure
2
1995
334
0.010
Why?
Heart Failure
1
1996
2128
0.010
Why?
Proportional Hazards Models
2
1998
1305
0.010
Why?
Adaptor Proteins, Signal Transducing
1
2006
528
0.010
Why?
Infusions, Intravenous
2
1996
537
0.010
Why?
Immunohistochemistry
1
2006
1688
0.010
Why?
Life Tables
2
1991
29
0.010
Why?
Tumor Cells, Cultured
2
1992
1061
0.010
Why?
Retrospective Studies
3
2010
16044
0.010
Why?
Nuclear Proteins
1
2006
1268
0.010
Why?
Recurrence
2
1994
1419
0.010
Why?
Aneuploidy
2
1992
153
0.010
Why?
Fluorouracil
2
1990
128
0.010
Why?
Multicenter Studies as Topic
1
1999
261
0.010
Why?
Drug Synergism
2
1990
239
0.010
Why?
Animals
5
1987
33792
0.010
Why?
Salvage Therapy
1
1999
193
0.010
Why?
Growth Disorders
1
1999
207
0.010
Why?
Incidence
2
1996
3039
0.010
Why?
Age Distribution
1
1998
406
0.010
Why?
Time Factors
3
1994
6219
0.010
Why?
Dipeptidyl Peptidase 4
2
1986
22
0.010
Why?
Dose-Response Relationship, Radiation
1
1996
66
0.010
Why?
Fatal Outcome
1
1997
355
0.010
Why?
Dacarbazine
2
1987
86
0.010
Why?
Brain Stem
1
1996
115
0.010
Why?
Reoperation
1
1998
818
0.010
Why?
Leukocyte Common Antigens
1
1995
90
0.010
Why?
Lymphocyte Count
1
1994
115
0.010
Why?
CD4 Lymphocyte Count
1
1995
230
0.010
Why?
Risk
1
1996
742
0.010
Why?
Gliosarcoma
1
1994
11
0.010
Why?
Fibrosarcoma
1
1994
28
0.010
Why?
Opportunistic Infections
1
1994
78
0.010
Why?
Rhabdomyosarcoma, Alveolar
1
1994
37
0.010
Why?
Immunoenzyme Techniques
1
1994
260
0.010
Why?
Glial Fibrillary Acidic Protein
1
1994
104
0.010
Why?
Immunophenotyping
1
1994
328
0.010
Why?
Oligodendroglioma
2
1983
24
0.010
Why?
Aminoisobutyric Acids
2
1983
9
0.010
Why?
Drug Resistance
1
1994
255
0.010
Why?
Rats, Inbred Strains
2
1983
229
0.010
Why?
Craniotomy
1
1994
108
0.010
Why?
Mitosis
1
1994
238
0.010
Why?
Lymphoma, Non-Hodgkin
1
1995
162
0.010
Why?
Chromosomes, Human, Pair 13
1
1992
50
0.010
Why?
Meningioma
1
1994
120
0.010
Why?
Myelography
1
1992
9
0.010
Why?
Meningeal Neoplasms
1
1994
183
0.010
Why?
Molecular Weight
1
1992
391
0.010
Why?
RNA, Neoplasm
1
1992
138
0.010
Why?
Oncogenes
1
1992
168
0.010
Why?
Skin Temperature
1
1971
19
0.010
Why?
Neoplasm Invasiveness
1
1993
604
0.010
Why?
Meta-Analysis as Topic
1
1991
153
0.010
Why?
In Vitro Techniques
1
1992
966
0.010
Why?
Fetal Heart
1
1971
111
0.010
Why?
Leucovorin
1
1990
50
0.010
Why?
Cerebellar Neoplasms
1
1993
282
0.010
Why?
Mice
1
1987
17537
0.010
Why?
Regression Analysis
1
1991
770
0.010
Why?
Chromosome Mapping
1
1992
1081
0.010
Why?
Predictive Value of Tests
1
1995
2112
0.010
Why?
Chromatography, High Pressure Liquid
1
1990
338
0.010
Why?
Risk Assessment
1
1998
3325
0.010
Why?
Remission Induction
1
1989
300
0.000
Why?
Dactinomycin
1
1987
67
0.000
Why?
Brain
2
1994
2967
0.000
Why?
Immunochemistry
1
1986
30
0.000
Why?
Saline Solution, Hypertonic
1
1987
20
0.000
Why?
Carboplatin
1
1987
75
0.000
Why?
Osmolar Concentration
1
1986
174
0.000
Why?
Urologic Diseases
1
1987
44
0.000
Why?
Biomarkers, Tumor
1
1994
1439
0.000
Why?
Hematologic Diseases
1
1987
78
0.000
Why?
RNA, Messenger
1
1992
2809
0.000
Why?
Embryonal Carcinoma Stem Cells
1
1985
10
0.000
Why?
Clone Cells
1
1985
163
0.000
Why?
Wilms Tumor
1
1985
111
0.000
Why?
Lymphoma
1
1987
324
0.000
Why?
Acute Disease
1
1987
1093
0.000
Why?
Methylnitrosourea
1
1983
19
0.000
Why?
Choroid Plexus
1
1983
23
0.000
Why?
Subarachnoid Space
1
1983
24
0.000
Why?
Capillary Permeability
1
1983
77
0.000
Why?
Neoplastic Stem Cells
1
1985
294
0.000
Why?
Nervous System Diseases
1
1987
372
0.000
Why?
Biological Transport
1
1983
347
0.000
Why?
Head and Neck Neoplasms
1
1987
481
0.000
Why?
Chromosome Deletion
1
1985
638
0.000
Why?
Blood Flow Velocity
1
1983
449
0.000
Why?
Kinetics
1
1983
1312
0.000
Why?
Pregnancy
2
1983
7138
0.000
Why?
Hippocampus
1
1983
819
0.000
Why?
Carcinoma, Hepatocellular
1
1985
938
0.000
Why?
Middle Aged
1
1994
25992
0.000
Why?
HOROWITZ's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (284)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_